Bioinformatics-based discovery and identification of new biologically active peptides for GPCR deorphanization.
Owing to their involvement in many physiological and pathological processes, G-protein-coupled receptors (GPCRs) are interesting targets for drug development. Approximately, 100 endoGPCRs lack their natural ligands and remain orphan (oGPCRs). Consequently, oGPCR deorphanization appears a promising research field for the development of new therapeutics. On the basis of the knowledge of currently known GPCR/ligand couples, some oGPCRs may be targeted by peptides. However, to find new drugs for GPCRs, Genepep has developed a dedicated bioinformatics platform to screen transcriptomic databases for the prediction of new GPCR ligands. The peptide lists generated include specific data, such as chemical and physical properties, the occurrence of post-translational modifications (PTMs) and an annotation referring to the location and expression level of the related putative genes. This information system allows a selection through series of biological criteria of approximately 10 000 natural peptides including already known GPCR ligands and potential new candidates for GPCR deorphanization. The most promising peptides for functional assay screening and future development as therapeutic agents are under evaluation.
Colette
Jean
J
Genepep S.A., Zone d'activité les Baronnes, Ateliers Relais, Lots 4 & 5, 34 730 Prades le Lez, France.
Avé
Emilie
E
Grenier-Boley
Benjamin
B
Coquel
Anne-Sophie
AS
Lesellier
Karine
K
Puget
Karine
K
D000818:Animals; D019295:Computational Biology; D015195:Drug Design; D006801:Humans; D008024:Ligands; D010455:Peptides / Q000737:chemistry* / Q000378:metabolism*; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism*
D008024:Ligands; D010455:Peptides; D043562:Receptors, G-Protein-Coupled